loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 26276 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Dead Sea Periclase

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Aspen API. More than just an API.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Dead Sea Periclase (1)

    filter

    01 MAGNESIUM OXIDE (1)

    filter

    01 Israel (1)

    filter

    01 Active (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    DEAD SEA BROMINE CO LTD

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Israel
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      MAGNESIUM OXIDE

      PDF Supplier PDF
      URL Supplier Web Content
      26276
      Active
      2012-07-30
      N/A
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Drug Master Files (DMF) for 26276 of Dead Sea Bromine Co Ltd

      Looking for Drug Master Files (DMF) for 26276 of Dead Sea Bromine Co Ltd 1

      20

      Dead Sea Bromine Co Ltd, based in Israel, is a pharmaceutical company.

      One of their notable products is MAGNESIUM OXIDE, with a corresponding US DMF Number 26276.

      Remarkably, this DMF maintains an Active status since its submission on July 30, 2012, highlighting commitment to regulatory compliance.

      Post Enquiry
      POST ENQUIRY